Clinical Trial Update: Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the chemopreventive effect of combining celecoxib and metformin in familial adenomatous polyposis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• CELEBREX (Celecoxib)
• Glucophage (metformin)

Snippet

Sponsor: Yonsei University | Conditions: Familial Adenomatous Polyposis | Phase 3 | Status: RECRUITING